MoonLake Immunotherapeutics. Every tracked FinTwit mention of $MLTX, newest first. 16 mentions since the first on Aug 28, 2025. See the price chart.
February 2026 · 1 mention
Feb 22
Adam Feuerstein ✡️ — $MLTX befuddled by sonelokimab inability to beat a placebo in clinical trials, so it just eliminated the placebo!
The only way Moonlake can win.↗
January 2026 · 2 mentions
Jan 8
Adam Feuerstein ✡️ — $MLTX - The FDA says we can file for approval with data from failed trials that show our drug is no better and likely worse than our competitors. We're so excited!↗
Jan 6
Adam Feuerstein ✡️ — @SolomouYiannis @Sanctuary_Bio Thankfully, I was right about $MLTX.↗
October 2025 · 1 mention
Oct 3
Adam Feuerstein ✡️ — A suggestion: No more Dirk $MLTX dunking. Let's all be better. Move on.↗
September 2025 · 11 mentions
Sep 29
Adam Feuerstein ✡️ — A coda on $MLTX
MoonLake can’t spin away this disastrous autoimmune drug failure
This was one of the biotech’s most contentious bull-bear fights. The bears won.
https://t.co/GQo…↗
Sep 28
Adam Feuerstein ✡️ — I wrote again on $MLTX in Nov. 2023
https://t.co/ilDcTePkQY
MoonLake’s credibility takes another hit with mid-stage study spin job
MoonLake Immunotherapeutics, a Swiss biotech,…↗
Sep 28
Adam Feuerstein ✡️ — Here's another $MLTX piece from June 2025
MoonLake Immunotherapeutics is for sale? This sounds like a cry for help
MoonLake management must be worried about the outcome of its up…↗
Adam Feuerstein ✡️ — Second newsletter item:
How to analyze the results of MoonLake’s $MLTX looming HS study readout
It's all about how you account for antibiotic use.
https://t.co/ri1ANO9feN↗
— On $MLTX ... foreseeing today's Ph3 failure.
My stories are published behind STAT's paywall, but for those who are not subscribers, I've written critically / skeptically about so…
Adam Feuerstein ✡️ — Damn, step away for a few minutes and miss a Sunday PR from $MLTX
https://t.co/aAASu0Dy4g↗
Sep 28
Adam Feuerstein ✡️ — @DickMedChem Yes. This is what I wrote about $MLTX in my June 5 newsletter:
MoonLake management must be worried about the outcome of its upcoming and much-hyped Phase 3 studies.…↗
Sep 28
Adam Feuerstein ✡️ — $MLTX
From my Aug. 28 newsletter
How to analyze the results of MoonLake's looming VELA study readout
MoonLake Immunotherapeutics has guided to a September readout for the sonel…↗
Sep 26
Adam Feuerstein ✡️ — $MLTX survey: Your prediction for "HS antibiotic" HiSCR75?↗
Sep 19
Adam Feuerstein ✡️ — Happy Friday evening.
$MLTX and $QURE readouts still pending as we roll towards the end of September.↗